Gene: LMNTD2
Official Full Name: lamin tail domain containing 2provided by HGNC
Gene Summary: Predicted to be a structural constituent of chromatin. Predicted to act upstream of or within positive regulation of mRNA splicing, via spliceosome. Predicted to be active in lamin filament. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO21054 | LMNTD2 Knockout cell line (HeLa) | Human | LMNTD2 | 1:3~1:6 | Negative | Online Inquiry |
KO21055 | LMNTD2 Knockout cell line (HCT 116) | Human | LMNTD2 | 1:2~1:4 | Negative | Online Inquiry |
KO21056 | LMNTD2 Knockout cell line (A549) | Human | LMNTD2 | 1:3~1:4 | Negative | Online Inquiry |
LMNTD2 Gene Knockout Cell Lines are a revolutionary tool designed for advanced genetic research, specifically targeting the LMNTD2 gene, which has been implicated in various biological processes and diseases. These cell lines are meticulously engineered using CRISPR-Cas9 technology to create knockout models that allow for the precise study of gene function and the investigation of pathological conditions associated with LMNTD2 dysregulation.
The primary function of LMNTD2 Gene Knockout Cell Lines is to provide researchers with a controlled environment in which the effects of the absence of the LMNTD2 gene can be directly observed. The knockout mechanism disrupts the gene’s transcription, leading to the loss of protein expression. This enables the evaluation of downstream signaling pathways and biological responses, thereby facilitating a deeper understanding of the gene's role in cellular biology, including potential implications in cancer research and metabolic disorders.
From a scientific standpoint, LMNTD2 Gene Knockout Cell Lines are invaluable in validating therapeutic targets and drug discovery processes, paving the way for novel treatment strategies. In clinical settings, understanding the LMNTD2 gene's function could lead to breakthroughs in diagnosing and potentially treating associated diseases, thus underscoring their significance in translational research.
Compared to alternative models, such as whole organism knockout or silencing approaches, our LMNTD2 Gene Knockout Cell Lines offer high specificity and efficiency with reduced off-target effects, allowing for more reliable experimental outcomes. Additionally, our models are ready to use and compatible with a variety of assays, enhancing workflow efficiency for researchers.
Investing in LMNTD2 Gene Knockout Cell Lines translates to an opportunity to advance genetic research with precise and robust tools that reflect our commitment to delivering cutting-edge biological products. Our expertise in genetic engineering and commitment to quality assurance ensure that researchers and clinicians can trust our products to accelerate their investigations and therapeutic developments.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.